Treatment effects of reverse total shoulder arthroplasty – a simple method to measure outcomes at 6, 12, 24 and 60 months for each patient

Abstract Background Although shoulder arthroplasty is less common than knee or hip arthroplasty, the number of procedures being performed is increasing rapidly. The treatment effect is a simple method to measure outcome of joint replacement. The method was applied to measure results of total hip/kne...

Full description

Bibliographic Details
Main Authors: Joerg Huber, Ulrich Irlenbusch, Max J. Kääb, Falk Reuther, Georges Kohut, Andy Judge
Format: Article
Language:English
Published: BMC 2020-06-01
Series:BMC Musculoskeletal Disorders
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12891-020-03427-7
id doaj-fa815aaf5c3c4db387c092bb73386e15
record_format Article
spelling doaj-fa815aaf5c3c4db387c092bb73386e152020-11-25T03:05:23ZengBMCBMC Musculoskeletal Disorders1471-24742020-06-012111810.1186/s12891-020-03427-7Treatment effects of reverse total shoulder arthroplasty – a simple method to measure outcomes at 6, 12, 24 and 60 months for each patientJoerg Huber0Ulrich Irlenbusch1Max J. Kääb2Falk Reuther3Georges Kohut4Andy Judge5Department of Orthopedics, Stadtspital TriemliOrthopedic Clinics, MarienstiftSportorthopädicum StraubingDRK Kliniken KöpenickClinique generaleMusculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Learning & Research Building, Southmead HospitalAbstract Background Although shoulder arthroplasty is less common than knee or hip arthroplasty, the number of procedures being performed is increasing rapidly. The treatment effect is a simple method to measure outcome of joint replacement. The method was applied to measure results of total hip/knee arthroplasty but not yet for shoulder arthroplasty. Methods Included were patients with unilateral cuff arthropathy (Hamada grades > = 2) treated with reversed total shoulder arthroplasty (RSA) in this prospective multicenter study. The patients were assessed with the ASES questionnaire. The treatment effects (TE) was calculated for each patient. TE = score reduction/baseline score. A positive TE means amelioration, TE = 0 unchanged, and a negative TE means worse. The primary aim was to calculate the TE’s for RSA at 6, 12, 24, and 60 months postoperatively. The secondary aim was to analyze the influence of confounders (preoperative Hamada grade, age, gender, dominance, side of the affected shoulder, general co-morbidities measured using ASA grade). Results Two hundred three patients were included for this analysis of whom 183 patients had a complete 2 year follow up. Two years postoperatively the mean ASES score augmented significant from 20.5 to 78.7 (p < 0.001). The 2 year TE’s ranged from 1 to 0.09. We had no patient with a negative TE. A higher Hamada grade was associated with better TE’s (Hamada grade 4+ vs. 2, p-value 0.042). For age and dominant side there were weak associations where those aged 80+ and dominant side had better TE’s. The patients with higher ASA grade had lower TE’s (ASA grade 4+ vs. 1, p-value 0.013). The mean TE’s were 0.77 at 6-months, 0.81 at 1 year, 0.76 at 2 years and 0.73 at 5 years. Conclusions The outcome for reverse shoulder arthroplasty can be measured with the treatment effect method; the 2 years TE’s vary from 1 to 0.09. The mean treatment effects change little in the first five postoperative years (from 0.73 to 0.81). The confounders for better TE’s were: higher severity of cuff arthropathy (Hamada grade 3, 4 and 5), less co-morbidities (ASA Grade 1), higher age (80+) and dominant side. Gender did not influence the 2-year TE’s. Trial registration Comité intercantonal d’éthique (Jura, Fribourg, Neuchâtel), number 01/2008, 24.09.2008.http://link.springer.com/article/10.1186/s12891-020-03427-7Cuff arthropathyReverse shoulder arthroplastyTreatment effectOutcomeConfounders
collection DOAJ
language English
format Article
sources DOAJ
author Joerg Huber
Ulrich Irlenbusch
Max J. Kääb
Falk Reuther
Georges Kohut
Andy Judge
spellingShingle Joerg Huber
Ulrich Irlenbusch
Max J. Kääb
Falk Reuther
Georges Kohut
Andy Judge
Treatment effects of reverse total shoulder arthroplasty – a simple method to measure outcomes at 6, 12, 24 and 60 months for each patient
BMC Musculoskeletal Disorders
Cuff arthropathy
Reverse shoulder arthroplasty
Treatment effect
Outcome
Confounders
author_facet Joerg Huber
Ulrich Irlenbusch
Max J. Kääb
Falk Reuther
Georges Kohut
Andy Judge
author_sort Joerg Huber
title Treatment effects of reverse total shoulder arthroplasty – a simple method to measure outcomes at 6, 12, 24 and 60 months for each patient
title_short Treatment effects of reverse total shoulder arthroplasty – a simple method to measure outcomes at 6, 12, 24 and 60 months for each patient
title_full Treatment effects of reverse total shoulder arthroplasty – a simple method to measure outcomes at 6, 12, 24 and 60 months for each patient
title_fullStr Treatment effects of reverse total shoulder arthroplasty – a simple method to measure outcomes at 6, 12, 24 and 60 months for each patient
title_full_unstemmed Treatment effects of reverse total shoulder arthroplasty – a simple method to measure outcomes at 6, 12, 24 and 60 months for each patient
title_sort treatment effects of reverse total shoulder arthroplasty – a simple method to measure outcomes at 6, 12, 24 and 60 months for each patient
publisher BMC
series BMC Musculoskeletal Disorders
issn 1471-2474
publishDate 2020-06-01
description Abstract Background Although shoulder arthroplasty is less common than knee or hip arthroplasty, the number of procedures being performed is increasing rapidly. The treatment effect is a simple method to measure outcome of joint replacement. The method was applied to measure results of total hip/knee arthroplasty but not yet for shoulder arthroplasty. Methods Included were patients with unilateral cuff arthropathy (Hamada grades > = 2) treated with reversed total shoulder arthroplasty (RSA) in this prospective multicenter study. The patients were assessed with the ASES questionnaire. The treatment effects (TE) was calculated for each patient. TE = score reduction/baseline score. A positive TE means amelioration, TE = 0 unchanged, and a negative TE means worse. The primary aim was to calculate the TE’s for RSA at 6, 12, 24, and 60 months postoperatively. The secondary aim was to analyze the influence of confounders (preoperative Hamada grade, age, gender, dominance, side of the affected shoulder, general co-morbidities measured using ASA grade). Results Two hundred three patients were included for this analysis of whom 183 patients had a complete 2 year follow up. Two years postoperatively the mean ASES score augmented significant from 20.5 to 78.7 (p < 0.001). The 2 year TE’s ranged from 1 to 0.09. We had no patient with a negative TE. A higher Hamada grade was associated with better TE’s (Hamada grade 4+ vs. 2, p-value 0.042). For age and dominant side there were weak associations where those aged 80+ and dominant side had better TE’s. The patients with higher ASA grade had lower TE’s (ASA grade 4+ vs. 1, p-value 0.013). The mean TE’s were 0.77 at 6-months, 0.81 at 1 year, 0.76 at 2 years and 0.73 at 5 years. Conclusions The outcome for reverse shoulder arthroplasty can be measured with the treatment effect method; the 2 years TE’s vary from 1 to 0.09. The mean treatment effects change little in the first five postoperative years (from 0.73 to 0.81). The confounders for better TE’s were: higher severity of cuff arthropathy (Hamada grade 3, 4 and 5), less co-morbidities (ASA Grade 1), higher age (80+) and dominant side. Gender did not influence the 2-year TE’s. Trial registration Comité intercantonal d’éthique (Jura, Fribourg, Neuchâtel), number 01/2008, 24.09.2008.
topic Cuff arthropathy
Reverse shoulder arthroplasty
Treatment effect
Outcome
Confounders
url http://link.springer.com/article/10.1186/s12891-020-03427-7
work_keys_str_mv AT joerghuber treatmenteffectsofreversetotalshoulderarthroplastyasimplemethodtomeasureoutcomesat61224and60monthsforeachpatient
AT ulrichirlenbusch treatmenteffectsofreversetotalshoulderarthroplastyasimplemethodtomeasureoutcomesat61224and60monthsforeachpatient
AT maxjkaab treatmenteffectsofreversetotalshoulderarthroplastyasimplemethodtomeasureoutcomesat61224and60monthsforeachpatient
AT falkreuther treatmenteffectsofreversetotalshoulderarthroplastyasimplemethodtomeasureoutcomesat61224and60monthsforeachpatient
AT georgeskohut treatmenteffectsofreversetotalshoulderarthroplastyasimplemethodtomeasureoutcomesat61224and60monthsforeachpatient
AT andyjudge treatmenteffectsofreversetotalshoulderarthroplastyasimplemethodtomeasureoutcomesat61224and60monthsforeachpatient
_version_ 1724678889429532672